ABVC BioPharma | 8-K: Current report
ABVC BioPharma | 424B4: Prospectus
ABVC BioPharma | 424B4: Prospectus
ABVC BioPharma | 424B4: Prospectus
ABVC BioPharma | 424B4: Prospectus
ABVC BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.
ABVC BioPharma | 8-K: Current report
ABVC BioPharma | 10-Q: Q3 2024 Earnings Report
ABVC BioPharma | 8-K: Current report
ABVC BioPharma | 424B4: Prospectus
ABVC BioPharma | 8-K: Current report
ABVC BioPharma | 8-K: Current report
ABVC BioPharma | 8-K: Current report
ABVC BioPharma | 424B4: Prospectus
ABVC BioPharma | 424B4: Prospectus
ABVC BioPharma | 8-K: Current report
ABVC BioPharma | 10-Q: Q2 2024 Earnings Report
ABVC BioPharma | 424B5: Prospectus
ABVC BioPharma | 424B5: Prospectus
ABVC BioPharma | EFFECT: Others
No Data